Global Biospecimen Leader to Unveil Transformative Tool for Oncology Studies HUNTSVILLE, Ala. – Discovery Life Sciences (Discovery), a global leader in biospecimen solutions and specialty lab services, announced today that it will launch a new product to help advance oncology research, Tumoroid Cell Lines, OncoPro™ Medium-Derived, at  Precision Med Tri-Con 2025, March 11-13 in San Diego, California.    [...]

Tolochenaz, Switzerland —  Nanolive SA proudly announces its latest innovation, the Smart Mitochondrial AssayLIVE, the first label-free tool for real-time mitochondrial analysis. This AI-powered assay provides unprecedented accuracy in studying mitochondrial dynamics while preserving cell viability, setting a new standard for drug discovery, toxicology, and disease research. Figure 1: Nanolive’s holotomographic imaging and mitochondrial detection. [...]

Investment lead by Foresight Group secured alongside Polish grant funding agency PARP   Scottishbiotech engineering company uFraction8 has secured £3.4m in new investment following the completion of a funding round led by the Foresight Group. Based in Falkirk with a fully-owned subsidiary in Poland, uFraction8’s microfiltration technology is designed to optimise cell and biomass production,offering [...]

MARCO ISLAND, Fla. -- Complete Genomics, a leading innovator in genomic sequencing, today unveiled its latest high-performance sequencing solutions at the 2025 Advances in Genome Biology and Technology (AGBT) General Meeting. The newly introduced DNBSEQ-T1+* and DNBSEQ-E25 Flash* are designed to deliver speed, flexibility, and efficiency, empowering researchers with faster, high-quality genomic data. DNBSEQ-T1+: Mid-Throughput Sequencing with Industry-Leading Speed The [...]

OPHiA GENETICS enables institutions across the globe to launch world-class oncology testing BOSTON, MA and ROLLE, Switzerland -- SOPHiA GENETICS (Nasdaq: SOPH), a pioneer in AI healthcare technology and a leader in data-driven medicine, announced a new milestone in the global adoption of its groundbreaking cancer testing applications MSK-ACCESS® powered with SOPHiA DDM™ and MSK-IMPACT® powered with SOPHiA DDM™. Thirty-seven prominent institutions, including top researchers [...]

BOSTON -- Volta Labs, a leading genomics applications company, today announced its four strategic focus areas for 2025 and the expansion of the Callisto App menu to include RNA library prep and single-cell prep, and multi-sequencer capabilities. Key strategic focus areas for Volta Labs in 2025 are: Launching DNA, RNA and single-cell preps for all labs [...]

Vancouver, British Columbia -- Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope Innovations", "Telescope", or the "Company") is a leading developer of advanced technologies and services for the global pharmaceutical and high-value chemical industries. The Company is pleased to provide an update on its Self-Driving Lab ("SDL") technology, which integrates AI, robotics, advanced [...]

Accomplished marketing leader to drive strategic growth and customer-first initiatives NEWARK, Calif. -- Vector Laboratories, a manufacturing partner of reagents and critical components for the development and production of life sciences tools, diagnostics, and clinical-stage biotherapeutics, today announced the appointment of Ashley Scholz as Vice President of Marketing. Ashley brings over 16 years of experience in marketing [...]

Albert’s AI-enabled platform transforms materials science R&D and accelerates chemical innovation OAKLAND, Calif. -- Albert Invent, whose end-to-end R&D platform accelerates chemical innovation in materials science through the application of AI and machine learning, today announced a growth funding round led by J.P. Morgan Private Capital’s Growth Equity Partners, with participation from Coatue and TCV. This [...]

Cambridge, UK – Cresset, a leading provider of integrated in silico solutions for small molecule drug discovery announces the release of its Flare platform V10, bringing enhanced scientific features for both computational and medicinal chemists. The latest release includes significantly enhanced Free Energy Perturbation (FEP) calculations with the inclusion of Absolute FEP, Protein-protein docking, and Protein-Ligand [...]